| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.3 |